Klein Lawrence Otto has filed 5 insider transactions across 2 companies since January 2025.
Most recent transaction: a sale of 1729 shares of Oruka Therapeutics, Inc. ($ORKA) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Oruka Therapeutics, Inc. | $ORKA | Klein Lawrence Otto | Chief Executive Officer | S | Common Stock | 1729 | $41.30 | 927,309.0000 | 42,095,951 | 0.19% | 0.00% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Klein Lawrence Otto | Chief Executive Officer | A | Common Stock | 76700 | $0.00 | 929,038.0000 | 42,095,951 | 9.00% | 0.18% |
| Jan. 23, 2026 | Oruka Therapeutics, Inc. | $ORKA | Klein Lawrence Otto | Chief Executive Officer | A | Employee Stock Option (right to buy) | 306700 | $0.00 | 306,700.0000 | 42,095,951 | 9999.99% | 0.73% |
| April 29, 2025 | Jade Biosciences, Inc. | $JBIO | Klein Lawrence Otto | Not found | A | Stock Option (Right to Buy) | 23017 | $0.00 | 23,017.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2025 | Oruka Therapeutics, Inc. | $ORKA | Klein Lawrence Otto | Chief Executive Officer | A | Employee Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 16,789,362 | 9999.99% | 1.37% |